1
PD and PK Profiles of Switching Between Cangrelor and Ticagrelor Following Ticagrelor Pre-treatment
Condition(s):Coronary Artery DiseaseLast Updated:February 7, 2022Completed
KENGREAL: 39 Clinical Trials, Page 1 of 4
Hide Studies Not Open or Pending
2
Cangrelor in ST-Elevation Myocardial Infarction to Decrease Infarct Size
Condition(s):STEMI – ST Elevation Myocardial InfarctionLast Updated:June 30, 2020Terminated
3
Cangrelor in Comatose Survivors of OHCA Undergoing Primary PCI
Condition(s):Out-Of-Hospital Cardiac Arrest; Acute Coronary SyndromeLast Updated:December 3, 2021Completed
4
Pharmacodynamic and Pharmacokinetic of Switching From Cangrelor to Prasugrel in ACS Patients Undergoing PCI
Condition(s):Coronary Artery Disease; Acute Coronary SyndromeLast Updated:April 12, 2022Recruiting
5
Platelet Inhibition With Cangrelor and Crushed Ticagrelor in STEMI
Condition(s):ST Segment Elevation Myocardial Infarction; Percutaneous Coronary InterventionLast Updated:September 9, 2020Completed
6
Cangrelor Prasugrel Transition Study
Condition(s):Coronary Artery DiseaseLast Updated:June 24, 2015Completed
7
Cangrelor Following Ticagrelor Loading vs Ticagrelor Loading Alone in STEMI
Condition(s):STEMILast Updated:December 27, 2017Completed
8
Cangrelor to Clopidogrel or Prasugrel Transition Study
Condition(s):Coronary Artery Disease (CAD)Last Updated:February 26, 2020Completed
9
Cangrelor Ticagrelor Transition Study
Condition(s):Coronary Artery DiseaseLast Updated:May 19, 2014Completed
10
Cangrelor Neonatal PK/PD and Safety Study
Condition(s):Partial Obstruction of Systemic to Pulmonary Artery Shunt; Complete Obstruction of Systemic to Pulmonary Artery ShuntLast Updated:June 16, 2021Completed